When it comes to brain tumor awareness, I do not think that anyone can argue with the fact that there are many therapies to take into consideration. You want to make sure that these growths are targeted, which is something that cannot be done unless the best procedures are set in place. What can be said about the ICT-107 vaccine, you may wonder? Judging from a recent report, it seems as though this one may be able to prove especially strong when it comes to survival rates amongst patients.
Medical News Today posted an article in regards to this condition, which is something that cannot be overlooked. It spoke quite a bit about the idea of glioblastoma multiforme, which seems to be condition that is targeted as far as this procedure is concerned. Keep in mind that this type of brain tumor is one that is far more aggressive, as well as more common, than any other that can be considered. This type of information is one that various organizations, Voices against Brain Cancer included, can relay to you.
When it comes to the cells that are involved in this particular condition, regeneration seems to come about rather quickly. This is due, at least to some degree, to the blood stream that seems to be rather constant within the body. This is a point that the American Brain Tumor Association went into detail about. In addition, it was said that the risk of the condition increases with age - especially with men - but it seems like it can come about in anyone, regardless of factors like age or gender.
There was a study done by the Cedars-Sinai Medical Group that would put to use a vaccine referred to as ICT-107. In essence, what this vaccine would do is alert the immune system to the presence of cancerous cells before they would be targeted with a tumor-killing response. Specifically, it would be able to target six different antigens that are responsible for the consistency of these particular growths. Once the typical surgical methods were done, the vaccine would be administered three times a week at two-week intervals.
The results were positive, as it seems as though seven of the original sixteen patients were able to see extend survival rates. This would range between 60.7 and 82.7 months, which is quite extensive when considering survival rates for patients. In fact, six of the people involved in the study were said to be "progression-free." This means that not only did these patients have to worry about tumors coming back but they did not have to follow up with further treatment later on, which speaks volumes about the procedure in question.
Medical News Today posted an article in regards to this condition, which is something that cannot be overlooked. It spoke quite a bit about the idea of glioblastoma multiforme, which seems to be condition that is targeted as far as this procedure is concerned. Keep in mind that this type of brain tumor is one that is far more aggressive, as well as more common, than any other that can be considered. This type of information is one that various organizations, Voices against Brain Cancer included, can relay to you.
When it comes to the cells that are involved in this particular condition, regeneration seems to come about rather quickly. This is due, at least to some degree, to the blood stream that seems to be rather constant within the body. This is a point that the American Brain Tumor Association went into detail about. In addition, it was said that the risk of the condition increases with age - especially with men - but it seems like it can come about in anyone, regardless of factors like age or gender.
There was a study done by the Cedars-Sinai Medical Group that would put to use a vaccine referred to as ICT-107. In essence, what this vaccine would do is alert the immune system to the presence of cancerous cells before they would be targeted with a tumor-killing response. Specifically, it would be able to target six different antigens that are responsible for the consistency of these particular growths. Once the typical surgical methods were done, the vaccine would be administered three times a week at two-week intervals.
The results were positive, as it seems as though seven of the original sixteen patients were able to see extend survival rates. This would range between 60.7 and 82.7 months, which is quite extensive when considering survival rates for patients. In fact, six of the people involved in the study were said to be "progression-free." This means that not only did these patients have to worry about tumors coming back but they did not have to follow up with further treatment later on, which speaks volumes about the procedure in question.
About the Author:
Contact Voices Against Brain Cancer if you're searching for more information about brain tumor awareness and research.. Check here for free reprint license: ICT-107 & Speaking About Brain Tumor Awareness.
This article collected, selected and written by: Author Van Hoc
Niche blogs are sometimes referred to as splogs, but this is a misnomer. Even though the desired end result for the niche blogger is to make money...
Get Free Email Updates to your Inbox!
Post a Comment